| |
| |
|
| Insider
Information: |
Malik Rajesh |
| Relationship: |
|
| City: |
Research Triangle Park |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
161,787 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$449,768 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
161,787 |
|
|
| Total
Value |
$449,768 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -224.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
G1 Therapeutics Inc |
GTHX |
|
2024-05-13 |
161,787 |
2018-01-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-09-17 |
4 |
AS |
$65.78 |
$249,502 |
D/D |
(3,776) |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-09-17 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
12,176 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-10-15 |
4 |
AS |
$40.80 |
$157,497 |
D/D |
(3,776) |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-11-15 |
4 |
AS |
$39.71 |
$150,105 |
D/D |
(3,776) |
14,700 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-11-15 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
18,476 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-12-17 |
4 |
OE |
$4.17 |
$15,746 |
D/D |
3,776 |
18,476 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-12-17 |
4 |
AS |
$30.00 |
$113,280 |
D/D |
(3,776) |
14,700 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-03-08 |
4 |
OE |
$0.39 |
$1,638 |
D/D |
4,200 |
4,200 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-06-08 |
4 |
OE |
$0.39 |
$1,638 |
D/D |
4,200 |
8,400 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2020-01-23 |
4 |
OE |
$0.39 |
$1,950 |
D/D |
5,000 |
26,700 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2019-01-28 |
4 |
OE |
$0.39 |
$2,730 |
D/D |
7,000 |
21,700 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2024-05-13 |
4 |
S |
$4.79 |
$39,034 |
D/D |
(8,151) |
161,787 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2020-12-10 |
4 |
AS |
$20.06 |
$180,550 |
D/D |
(9,000) |
29,200 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2020-12-10 |
4 |
OE |
$4.17 |
$37,530 |
D/D |
9,000 |
38,200 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-05-10 |
4 |
OE |
$0.30 |
$3,000 |
D/D |
10,000 |
53,300 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2022-02-01 |
4 |
OE |
$0.30 |
$3,000 |
D/D |
10,000 |
73,855 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Ch. Medical Officer & SVP R&D |
• – – |
2018-10-15 |
4 |
OE |
$0.39 |
$18,203 |
D/D |
10,076 |
14,700 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
40,200 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
65,300 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2022-12-15 |
4 |
OE |
$0.30 |
$4,200 |
D/D |
14,000 |
87,207 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-01-22 |
4 |
AS |
$20.64 |
$309,591 |
D/D |
(15,000) |
40,200 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-01-22 |
4 |
OE |
$4.17 |
$62,550 |
D/D |
15,000 |
55,200 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-02 |
4 |
OE |
$0.39 |
$23,219 |
D/D |
15,000 |
58,300 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-02 |
4 |
AS |
$22.95 |
$344,192 |
D/D |
(15,000) |
43,300 |
0 |
% |
|
| GTHX |
G1 Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-23 |
4 |
OE |
$0.39 |
$5,850 |
D/D |
15,000 |
58,300 |
0 |
- |
|
62 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
